ArticleBMC pregnancy and childbirth2026
Predicting macrosomia and low birth weight with interpretable machine learning.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine Learning-Based Prediction of Fetal Macrosomia Using Maternal: A Pilot Study.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Abnormal birth weight, including macrosomia and low birth weight, constitutes a significant global health burden associated with both immediate neonatal risks and long-term metabolic complications. However, accurate prediction remains challenging due to fragmented clinical indicators and a lack of model interpretability, limitations often inherent in traditional statistical approaches that struggle with complex, high-dimensional data. This study developed interpretable machine learning models that integrate multifaceted maternal and fetal characteristics to enhance prediction accuracy and facilitate causal analysis. Key features were identified through statistical significance and correlation tests, and causal inference was conducted using G-computation. Among 14 evaluated models, XGBoost achieved optimal performance with AUC values of 0.997 for macrosomia and 0.992 for low birth weight. Feature importance analysis revealed distinct pathogenic pathways-metabolic and biometric factors were most predictive for macrosomia, whereas placental and hemodynamic factors dominated low birth weight prediction. These insights provide a robust and interpretable framework for early risk detection, supporting personalized antenatal management and improved perinatal healthcare strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.